SCHEMBL29925778

SCHEMBL29925778

CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 7/20 0.43
▸ TRHR P34981 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ACE2 Q9BYF1 4/20 0.41
▸ OPRK1 P41145 4/20 0.41
▸ MC4R P32245 1/20 0.40
▸ REN P00797 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29555036 0.96 ACE (0.41) ACETRHRMEN1KMT2AACE2
SCHEMBL29630560 0.92 OPRK1 (0.46) ACETRHRMEN1KMT2AOPRK1
SCHEMBL29590547 0.92 OPRK1 (0.46) ACETRHRMEN1KMT2AOPRK1
SCHEMBL29630596 0.91 MEN1 (0.43) ACETRHRMEN1KMT2AOPRK1
SCHEMBL29630457 0.90 MC4R (0.42) TRHRMC4RREN
SCHEMBL29630670 0.90 TRHR (0.42) ACETRHRACE2OPRK1
SCHEMBL30385689 0.89 REN (0.47) TRHRREN
SCHEMBL29630369 0.88 TRHR (0.41) ACETRHRACE2
SCHEMBL29630526 0.88 TRHR (0.41) ACETRHRACE2
SCHEMBL29590456 0.88 TRHR (0.41) ACETRHRACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051408-A1 FACTOR H VARIANTS FOR TREATMENT OF DISEASE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2025-02-13 — — US disclosed
US-12180254-B1 Factor H variants for treatment of disease THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2024-12-31 — — US disclosed
CN-115976105-A Compositions and methods for treating complement-mediated diseases 宾夕法尼亚州大学信托人 2023-04-18 — — CN disclosed
CN-108291216-B Compositions and methods for treating complement-mediated diseases 宾夕法尼亚州大学信托人 2022-09-16 — — CN disclosed
Send feedback